Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organon & Co.
(NY:
OGN
)
17.61
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024
October 09, 2024
From
Organon & Co.
Via
Business Wire
Organon, Howmet Aerospace And More: CNBC's 'Final Trades'
October 03, 2024
On CNBC's "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named ProShares Short QQQ as his final trade.
Via
Benzinga
P/E Ratio Insights for Organon
October 02, 2024
Via
Benzinga
Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
September 30, 2024
From
Organon & Co.
Via
Business Wire
3 Cheap High Dividend Stocks For Passive Income
August 30, 2024
These undervalued high yield stocks could return over 10% per year.
Via
Talk Markets
High Dividend 50: Organon & Co.
June 27, 2024
Organon & Co.’s current annual dividend is $1.12 per share. At around $20 per share, Organon stock has a high yield of 5.4%.
Via
Talk Markets
Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy
September 21, 2024
Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and...
Via
Talk Markets
Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B
September 18, 2024
Organon is set to acquire Roivant Sciences' Dermavant Sciences, known for developing immuno-dermatology treatments, including FDA-approved Vtama cream for plaque psoriasis. The deal, valued up to $1.2...
Via
Benzinga
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
September 18, 2024
From
Organon & Co.
Via
Business Wire
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
September 18, 2024
From
Roivant Sciences
Via
GlobeNewswire
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
September 06, 2024
JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.
Via
Benzinga
Organon Stock Sees Relative Strength Rating Rise To 91
August 27, 2024
On Tuesday, Organon[ stock hit an key technical milestone, seeing its Relative Strength Rating jump to 91, up from 88 the day before.
Via
Investor's Business Daily
Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
August 20, 2024
On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier.
Via
Investor's Business Daily
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
August 20, 2024
From
Organon & Co.
Via
Business Wire
OGN Stock Earnings: Organon Beats EPS, Misses Revenue for Q2 2024
August 06, 2024
OGN stock results show that Organon beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Organon Reports Results for the Second Quarter Ended June 30, 2024
August 06, 2024
From
Organon & Co.
Via
Business Wire
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
July 30, 2024
Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks."
Via
Benzinga
Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024
July 09, 2024
From
Organon & Co.
Via
Business Wire
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
July 06, 2024
These exchange-traded funds should keep the income flowing in regularly.
Via
The Motley Fool
Topics
ETFs
Value Investing Is Back! 3 Stocks With Strong Fundamentals to Buy Now
June 26, 2024
Uncover three top value stocks to buy with robust fundamentals for stable long-term growth amid turbulence.
Via
InvestorPlace
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
June 08, 2024
These stocks offer great dividends and more.
Via
The Motley Fool
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
May 24, 2024
From
Organon & Co.
Via
Business Wire
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
May 10, 2024
Via
Benzinga
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
May 07, 2024
From
Organon & Co.
Via
Business Wire
Organon Announces Proposed $1.0 Billion Senior Notes Offering
May 07, 2024
From
Organon & Co.
Via
Business Wire
Organon Beats On Q1, Women's Health Leads the Charge
May 02, 2024
Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.
Via
Benzinga
OGN Stock Earnings: Organon Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
OGN stock results show that Organon beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Organon Reports Results for the First Quarter Ended March 31, 2024
May 02, 2024
From
Organon & Co.
Via
Business Wire
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
May 01, 2024
While these sleeper stocks to buy don’t attract the spotlight, the lack of attention makes these ideas even more enticing.
Via
InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
May 01, 2024
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.